This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring

€500 savings end in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
THE SPRINGTIME PARTNERING EVENT
March 18–20, 2024 | Barcelona, SpainMarch 26–27, 2024 | Digital Partnering

Belyntic GmbH

Profile

In recent years, humanity has seen which health threats viral diseases can pose to life. At the same time, our bodies are equipped with a powerful network that needs to be unleashed to successfully overcome such threats. At Belyntic, we develop T-cell immunotherapies against diseases with significant unmet medical needs based on self-adjuvant peptide vaccines. We are about to start the preclinical development of our first vaccine candidate against PML, a rare but fatal neurodegenerative disease.